Durable Efficacy of Dolutegravir (DTG) Plus Lamivudine (3TC) in Antiretroviral Treatment-Naive Adults With HIV-1 Infection: 96-Week Results From the GEMINI Studies. Issue 2 (February 2020)

• Record Type: Journal Article
• Authors: Cahn, P.; Madero, J. Sierra; Arribas, J.; Antinori, A.; Ortiz, R.; Clarke, A.; Hung, C.; Rockstroh, J.; Girard, P.; Sievers, J.; Man, C.; Urbaityte, R.; Underwood, M.; Tenorio, A.; Pappa, K.; Wynne, B.; Gartland, M.; Aboud, M.; van Wyk, J.; Smith, K.; El-Bahy, Y.
• Is Part Of: Journal of infection and public health. Volume 13:Issue 2(2020)
• Page Start: 349
• Page End: 350
• Publication Date: 2020-02
• Subjects: Communicable diseases -- Periodicals; Public health -- Periodicals; Epidemiology -- Periodicals; Nosocomial infections -- Prevention -- Periodicals; Medical microbiology -- Periodicals; 614.4
• DOI: 10.1016/j.jiph.2020.01.118
• Languages: English
• ISSNs: 1876-0341